Strategies for mitigating an influenza pandemic
暂无分享,去创建一个
D. Cummings | C. Fraser | N. Ferguson | D. Burke | P. Cooley | James Cajka
[1] A. Langworthy,et al. An influenza simulation model for immunization studies. , 1976, American journal of epidemiology.
[2] T R Bender,et al. An outbreak of influenza aboard a commercial airliner. , 1979, American journal of epidemiology.
[3] I M Longini,et al. Estimating household and community transmission parameters for influenza. , 1982, American journal of epidemiology.
[4] L. A. Rvachev,et al. A mathematical model for the global spread of influenza , 1985 .
[5] I M Longini,et al. Statistical inference for infectious diseases. Risk-specific household and community transmission parameters. , 1988, American journal of epidemiology.
[6] R. May,et al. Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.
[7] A. J. Hall. Infectious diseases of humans: R. M. Anderson & R. M. May. Oxford etc.: Oxford University Press, 1991. viii + 757 pp. Price £50. ISBN 0-19-854599-1 , 1992 .
[8] P. Kaye. Infectious diseases of humans: Dynamics and control , 1993 .
[9] P. Ward,et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. , 1999, JAMA.
[10] HONG KONG INTERNATIONAL AIRPORT , 1999 .
[11] O. Diekmann,et al. Mathematical Epidemiology of Infectious Diseases: Model Building, Analysis and Interpretation , 2000 .
[12] Christl A. Donnelly,et al. Transmission intensity and impact of control policies on the foot and mouth epidemic in Great Britain , 2001, Nature.
[13] S. Cornell,et al. Dynamics of the 2001 UK Foot and Mouth Epidemic: Stochastic Dispersal in a Heterogeneous Landscape , 2001, Science.
[14] R. Axtell. Zipf Distribution of U.S. Firm Sizes , 2001, Science.
[15] C. Fraser,et al. Transmission Dynamics of the Etiological Agent of SARS in Hong Kong: Impact of Public Health Interventions , 2003, Science.
[16] J. Robins,et al. Transmission Dynamics and Control of Severe Acute Respiratory Syndrome , 2003, Science.
[17] N. Ferguson,et al. Planning for smallpox outbreaks , 2003, Nature.
[18] Susan Mallett,et al. A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals. , 2003, The Journal of antimicrobial chemotherapy.
[19] C. Fraser,et al. Public Health Risk from the Avian H5N1 Influenza Epidemic , 2004, Science.
[20] M. Cetron,et al. Public Health Interventions and SARS Spread, 2003 David M. Bell* and World Health Organization Working Group on Prevention of International and Community Transmission of SARS1 , 2004 .
[21] J. Oxford,et al. The Great Influenza: The Epic Story of the Deadliest Plague in History , 2004 .
[22] C. Viboud,et al. A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data , 2004, Statistics in medicine.
[23] T. Geisel,et al. Forecast and control of epidemics in a globalized world. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[24] Y. Xia,et al. Measles Metapopulation Dynamics: A Gravity Model for Epidemiological Coupling and Dynamics , 2004, The American Naturalist.
[25] J. Robins,et al. Transmissibility of 1918 pandemic influenza , 2004, Nature.
[26] A. Nizam,et al. Containing pandemic influenza with antiviral agents. , 2004, American journal of epidemiology.
[27] A. Nizam,et al. Containing Pandemic Influenza at the Source , 2005, Science.
[28] Steve Leach,et al. Potential Impact of Antiviral Drug Use during Influenza Pandemic , 2005, Emerging infectious diseases.
[29] T. Tsang,et al. Respiratory Infections during SARS Outbreak, Hong Kong, 2003 , 2005, Emerging infectious diseases.
[30] Angus Nicoll,et al. Avian influenza A (H5N1) infection in humans. , 2005, The New England journal of medicine.
[31] S. Dowell,et al. Human Disease from Influenza A (H5N1), Thailand, 2004 , 2005, Emerging infectious diseases.
[32] Jeffery K. Taubenberger,et al. Characterization of the 1918 influenza virus polymerase genes , 2005, Nature.
[33] D. Cummings,et al. Strategies for containing an emerging influenza pandemic in Southeast Asia , 2005, Nature.
[34] J. Farrar,et al. WRITING COMMITTEE OF THE WORLD HEALTH ORGANIZATION (WHO) CONSULTATION ON HUMAN INFLUENZA A/H5. AVIAN INFLUENZA A (H5N1) INFECTION IN HUMANS , 2005 .
[35] UK stocks up on antiviral drug to tackle flu outbreak , 2005, BMJ : British Medical Journal.
[36] Mark A. Miller,et al. Synchrony, Waves, and Spatial Hierarchies in the Spread of Influenza , 2006, Science.
[37] M Elizabeth Halloran,et al. Design and evaluation of prophylactic interventions using infectious disease incidence data from close contact groups , 2006, Journal of the Royal Statistical Society. Series C, Applied statistics.
[38] Keiji Fukuda,et al. Nonpharmaceutical Interventions for Pandemic Influenza, International Measures , 2006, Emerging infectious diseases.
[39] Krishna Rama-Murthy,et al. Modeling of United States Airline Fares -- Using the Official Airline Guide (OAG) and Airline Origin and Destination Survey (DB1B) , 2006 .
[40] P. Horby,et al. Nonpharmaceutical Interventions for Pandemic Influenza, National and Community Measures , 2006, Emerging infectious diseases.
[41] T. Geisel,et al. The scaling laws of human travel , 2006, Nature.
[42] P. M. Shearer,et al. Zipf Distribution of U . S . Firm Sizes , 2022 .